New findings, published in Cellular and Molecular Gastroenterology and Hepatology, show that the transcription factor CREB ...

Birelentinib has received FDA Fast Track Designation for relapsed/refractory chronic lymphocytic leukemia (CLL) or small ...

The FDA has granted accelerated approval to zongertinib for pretreated, HER2+ non-squamous NSC lung cancer, based on results ...

A Penn Medicine study has shown that tailoring chemotherapy doses based on genetic testing can significantly improve safety for gastrointestinal (GI) cancer patients. Screening for variants in two key ...